HemaSphere (Oct 2022)
P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET-adapted era. A single center retrospective study.
- Andrea Visentin,
- Alessandro Cellini,
- Chiara Adele Cavarretta,
- Leila Romano Gargarella,
- Francesco Angotzi,
- Valeria Ruocco,
- Simone Zoletto,
- Stefano Pravato,
- Marco Pizzi,
- Federica Vianello,
- Filippo Crimì,
- Stefania Vio,
- Michele Gregianin,
- Livio Trentin
Affiliations
- Andrea Visentin
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova
- Alessandro Cellini
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova
- Chiara Adele Cavarretta
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova
- Leila Romano Gargarella
- 2 Hematology and Bone Marrow unit, Hospital L’angelo, Mestre
- Francesco Angotzi
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova
- Valeria Ruocco
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova
- Simone Zoletto
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova
- Stefano Pravato
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova
- Marco Pizzi
- 3 General Pathology & Cytopathology Unit, Department of Medicine, University of Padova
- Federica Vianello
- 4 Radiotherapy Unit, Veneto Institute of Oncology IOV-IRCCS, Padova
- Filippo Crimì
- 5 Radiology Institute, Department of Medicine, University of Padova,
- Stefania Vio
- 6 Radiology unit, Azienda Ospedale Università Padova
- Michele Gregianin
- 7 Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCCS, Castelfranco Veneto
- Livio Trentin
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova
- DOI
- https://doi.org/10.1097/01.HS9.0000890588.66425.bf
- Journal volume & issue
-
Vol. 6
pp. 3 – 3
Abstract
No abstracts available.